Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Change in Receivables Depreciation & Amortization (CF)Depreciation and Depletion Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

RenovoRx (RNXT) Capital Expenditures (2025)

RenovoRx's Capital Expenditures history spans 1 years, with the latest figure at $2000.0 for Q1 2025.